Simultaneous determination of cefoxitin, cefuroxime, cephalexin and cephaloridine in plasma using HPLC and a column-switching technique
- 119 Downloads
- 28 Citations
Summary
A new high performance liquid chromatographic method was developed using a column-switching technique for the simultaneous determination of cephalexin, cefuroxime, cefoxitin and cephaloridine in plasma. The plasma samples were injected onto a precolumn packed with Corasil RP C18 (37–50 μm) after simple dilution with an internal standard solution in 0.01 M acetate buffer (pH 3.5). Polar plasma components were washed out using 0.01 M acetate buffer (pH 3.5). After valve switching, the concentrated drugs were desorbed in back-flush mode and separated on a Partisil ODS-3 column using acetonitrile in 0.02 M acetate buffer (pH 4.3) (15∶85, v/v) as the mobile phase. The method showed excellent precision with good sensitivity and speed with a detection limit of 0.5 μg/ml. The total analysis time per sample was less than 25 min, and the mean coefficients of variation for intra- and inter-assay were both less than 4.9 %.
This method has been successfully applied to plasma from rats after subcutaneous injection of cefuroxime.
Key Words
Column liquid chromatography Cephalosporins Column switching in HPLC On-line plasma sample clean-upPreview
Unable to display preview. Download preview PDF.
References
- [1]L.A. Wheeler, M. De Meo, B.D. Kirby, R.S. Jerauld, S.M. Finegold, J. Chromatogr.183, 357 (1980).Google Scholar
- [2]Z.H. Al-Rawi, S. Tabaqchali, Antimicrob. Agents Chemother.20, 25 (1981).Google Scholar
- [3]Y. Takagishi, K. Iwamoto, M., Nagata, H. Kato, Yakugaku Zasshi101, 843 (1981).Google Scholar
- [4]J.B. Lecaillon, M.C. Rouan, C. Souppart, N. Febvre, F. Juge, J. Chromatogr.228, 257 (1982).Google Scholar
- [5]M.C. Rouan, F. Abadie, A. Leclerc, F. Juge, J. Chromatogr.275, 133 (1983).Google Scholar
- [6]L.A. Danzer, Clin. Chem.29, 856 (1983).Google Scholar
- [7]S.A. Signs, T.M. File, J.S. Tan, Antimicrob. Agents Chemother.26, 652 (1984).Google Scholar
- [8]A.M. Brisson, J.B. Fourtillan, J. Chromatogr.223, 393 (1981).Google Scholar
- [9]C.E. Fasching, L.R. Peterson, Antimicrob. Agents Chemother.21, 628 (1982).Google Scholar
- [10]T. Annesley, K. Wilkerson, K. Matz, D. Giacherio, Clin. Chem.30, 908 (1984).Google Scholar
- [11]A. Ishihara, J. Sudo, T. Tanabe, J. Toxicol. Sci.10, 1 (1985).Google Scholar
- [12]G.W. Whitaker, T.D. Lindstrom, J. Liq. Chromatogr.11, 901 (1988).Google Scholar
- [13]Y. Toshimitsu, J. Kinami, K. Manbo, M. Okiyama, K. Okumura, Chemotherapy34 (suppl. 5), 337 (1986).Google Scholar
- [14]J.A. Adamovics, J. Pharm. Biomed. Anal.5, 267 (1987).Google Scholar
- [15]M.C. Rouan, J. Chromatogr.426, 335 (1988).Google Scholar
- [16]T.A. Emm, J. Leslie, M. Chai, L.J. Lesko, M.B. Perkal, J. Chromatogr.427, 162 (1988).Google Scholar
- [17]L.J. Little, D.J. Tompkins, O. Stahel, R.W. Frei, C.E.W. Goewie, J. Chromatogr.264, 183 (1983).Google Scholar
- [18]R. Wyss, F. Bucheli, J. Chromatogr.424, 303 (1988).Google Scholar
- [19]H.S. Lee, E.J. Kim, O.P. Zee, Y.J. Lee, Arch. Pharm. (Weinheim)322, 801 (1989).Google Scholar
- [20]H.S. Lee, E.J. Kim, O.P. Zee, Y.J. Lee, Arch. Pharm. Res.12, 108 (1989).Google Scholar